SEC Filing Details

Document Details

Form
Filing Date
Feb 22, 2018
Document Date
Feb 20, 2018
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Innoviva, Inc.
Issuer
THERAVANCE INC
Filer
WITEK THEODORE L JR

Copyright Nasdaq. Minimum 15 minutes delayed.

Contact

Innoviva Investor Relations & Media
650.238.9640

For business development inquiries,
please contact bd@inva.com.